Vimarsana
Biggest News Aggregation in the World

Vimta Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vimta Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vimta Labs Today - Breaking & Trending Today

Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 - Vimarsana News

Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024

Vimta Labs Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 796.88 million compared to INR 818.2...

Broader indices outperform; More than 100 smallcaps give double digit return - Vimarsana News

Broader indices outperform; More than 100 smallcaps give double digit return

For the short term, 22,620-22,630 will act as resistance for the Nifty. If the index sustains above 22,630, Nifty could attempt to break its all-time high of 22,776, says Hrishikesh Yedve, AVP Technical and Derivatives Research at Asit C. Mehta.

Vimta Labs Q3 FY24 Results Live : profit falls by 1.06% YOY - Vimarsana News

Vimta Labs Q3 FY24 Results Live : profit falls by 1.06% YOY

Vimta Labs Q3 FY24 Results Live : Revenue increased by 5.55% YoY & profit decreased by 1.06% YoY

In Vitro Toxicology Testing Market Global Forecast to 2028 - Ucommune International (NASDAQ:UK) - Vimarsana News

In Vitro Toxicology Testing Market Global Forecast to 2028 - Ucommune International (NASDAQ:UK)

"In March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion's ExD cell into its portfolio of advanced workflows, instruments, and analytical

In Vitro Toxicology Testing Market worth $17.1 billion by 2028 | strategic planning, business opportunity - Vimarsana News

In Vitro Toxicology Testing Market worth $17.1 billion by 2028 | strategic planning, business opportunity

The global in vitro toxicology testing market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $17.1 billion by 2028, growing at a CAGR of 9.5% from 2023 to 2028.